# Topical Cetirizine 1% vs Minoxidil 5% Gel in Treatment of Androgenetic Alopecia

> **NCT04293822** · PHASE4 · UNKNOWN · sponsor: **Assiut University** · enrollment: 60 (estimated)

## Conditions studied

- Androgenetic Alopecia

## Interventions

- **DRUG:** Cetirizine
- **DRUG:** Minoxidil

## Key facts

- **NCT ID:** NCT04293822
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06
- **Primary completion:** 2020-11
- **Final completion:** 2021-11
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04293822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04293822, "Topical Cetirizine 1% vs Minoxidil 5% Gel in Treatment of Androgenetic Alopecia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04293822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
